Costunolide alleviated DDC induced ductular reaction and inflammatory response in murine model of cholestatic liver disease

Tam, 2018, Cholangiopathies–towards a molecular understanding, EBioMedicine, 35, 381, 10.1016/j.ebiom.2018.08.024 De Martin, 2021, 211 Trussoni, 2022, Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target, Semin Immunopathol, 44, 527, 10.1007/s00281-022-00909-9 Prommaouan, 2022, Wax apple (Syzygium samarangense) fruit extract ameliorates endothelial dysfunction and liver damage in high cholesterol diet-fed rats, J. Tradit. Compl. Med., 12, 584 Guillot, 2021, Bile acid-activated macrophages promote biliary epithelial cell proliferation through integrin alphavbeta6 upregulation following liver injury, J Clin Invest, 131, 10.1172/JCI132305 Glaser, 2019, Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis, J Hepatol, 71, 783, 10.1016/j.jhep.2019.05.030 Lazaridis, 2004, The cholangiopathies: disorders of biliary epithelia, Gastroenterology, 127, 1565, 10.1053/j.gastro.2004.08.006 Karpen, 2020, Pediatric cholestasis: epidemiology, genetics, diagnosis, and current management, Clin Liver Dis, 15, 115, 10.1002/cld.895 de Vries, 2021, Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial, Gastroenterology, 160, 734, 10.1053/j.gastro.2020.10.001 Takamura, 2021, Changes in disease characteristics of primary biliary cholangitis: an observational retrospective study from 1982 to 2016, Hepatol Res : Off J Jpn Soc Hepatol, 51, 166, 10.1111/hepr.13586 Kjaergaard, 2021, Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis, J Hepatol, 74, 58, 10.1016/j.jhep.2020.07.028 Li, 2022, Short-term obeticholic acid treatment does not impact cholangiopathy in Cyp2c70-deficient mice with a human-like bile acid composition, Biochim Biophys Acta, Mol Cell Biol Lipids, 10.1016/j.bbalip.2022.159163 Nevens, 2018, Durable response in the markers of cholestasis through 36 months of open label extension study of obeticholic acid in primary biliary cholangitis, J Hepatol, 68, S224 Fuchs, 2022, Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology, Nat Rev Gastroenterol Hepatol, 1 Gulamhusein, 2020, Primary biliary cholangitis: pathogenesis and therapeutic opportunities, Nat Rev Gastroenterol Hepatol, 17, 93, 10.1038/s41575-019-0226-7 Cariello, 2022, The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment, Curr Opin Gastroenterol, 38, 136, 10.1097/MOG.0000000000000807 Kunst, 2020, From fatty hepatocytes to impaired bile flow: matching model systems for liver biology and disease, Biochem Pharmacol, 180, 10.1016/j.bcp.2020.114173 Meng, 2021, Dolomiaea souliei ethyl acetate extract protected against alpha-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism, Phytomedicine : Int J Phytother Phytopharmacol, 87, 10.1016/j.phymed.2021.153588 Butturini, 2014, Costunolide and Dehydrocostuslactone, two natural sesquiterpene lactones, ameliorate the inflammatory process associated to experimental pleurisy in mice, Eur J Pharmacol, 730, 107, 10.1016/j.ejphar.2014.02.031 Kim, 2019, Costunolide-A bioactive sesquiterpene lactone with diverse therapeutic potential, Int J Mol Sci, 20, 10.3390/ijms20122926 Wada, 1997, Inductive effects of bay leaf and its component costunolide on the mouse liver glutathione S-transferase, Nat Med, 51, 283 Mao, 2022, Costunolide protects against alcohol-induced liver injury by regulating gut microbiota, oxidative stress and attenuating inflammation in vivo and in vitro, Phytother Res, 36, 1268, 10.1002/ptr.7383 Ge, 2020, Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation, Br J Pharmacol, 177, 372, 10.1111/bph.14873 Ban, 2019, Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2, Cell Mol Biol Lett, 24, 1, 10.1186/s11658-019-0179-4 Wang, 2017, Costunolide protects lipopolysaccharide/d-galactosamine-induced acute liver injury in mice by inhibiting NF-kappaB signaling pathway, J Surg Res, 220, 40, 10.1016/j.jss.2017.06.083 Pose, 2019, 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine diet: a rodent model in cholestasis research, Methods Mol Biol, 1981, 249, 10.1007/978-1-4939-9420-5_16 Mariotti, 2019, Animal models of cholestasis: an update on inflammatory cholangiopathies, Biochim et Biophys Acta Mol Basis Dis, 1865, 954, 10.1016/j.bbadis.2018.07.025 Sato, 2019, Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets, Expert Opin Ther Targets, 23, 461, 10.1080/14728222.2019.1608950 Wen, 2021, Geniposide suppresses liver injury in a mouse model of DDC-induced sclerosing cholangitis, Phytother Res : PTR, 35, 3799, 10.1002/ptr.7086 Cossarizza, 2021, Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition), Eur J Immunol, 51, 2708, 10.1002/eji.202170126 Liu, 2020, Analysis of myeloid cells in mouse tissues with flow cytometry, STAR Protocols, 1, 10.1016/j.xpro.2020.100029 Xue, 2021, Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters, J Ethnopharmacol, 269, 10.1016/j.jep.2020.113706 Li, 2019, Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice, Phytomedicine : Int J Phytother Phytopharmacol, 62, 10.1016/j.phymed.2019.152948 Best, 2016, Macrophage depletion attenuates extracellular matrix deposition and ductular reaction in a mouse model of chronic cholangiopathies, PLoS One, 11, 10.1371/journal.pone.0162286 Fickert, 2007, A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis, Am J Pathol, 171, 525, 10.2353/ajpath.2007.061133 Wu, 2016, The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-beta1 biliary secretion in mice, Hepatology, 64, 865, 10.1002/hep.28622 Yang, 2016, Bile acids and the potential role in primary biliary cirrhosis, Digestion, 94, 145, 10.1159/000452300 Chiang, 2017, Bile acid metabolism and signaling in liver disease and therapy, Liver Res, 1, 3, 10.1016/j.livres.2017.05.001 Mariotti, 2018, Animal models of biliary injury and altered bile acid metabolism, Biochim et Biophys Acta Mol Basis Dis, 1864, 1254, 10.1016/j.bbadis.2017.06.027 Yang, 2018, Metabolomic analysis of cholestatic liver damage in mice, Food Chem Toxicol : Int J Publ Br Ind Biol Res Assoc, 120, 253, 10.1016/j.fct.2018.07.022 Paulo, 2022, Liver and gall bladder channel parallels in the hippocratic corpus and Huang Di Nei Jing with theoretical considerations, J. Tradit. Compl. Med., 12, 384 Kohara, 2020, High-throughput screening to evaluate inhibition of bile acid transporters using human hepatocytes isolated from chimeric mice, Toxicol Sci : Off J Soc Toxicol, 173, 347, 10.1093/toxsci/kfz229 Boyer, 2021, Bile formation and secretion: an update, J Hepatol, 75, 190, 10.1016/j.jhep.2021.02.011 Chen, 2015, Strategies to prevent and reverse liver fibrosis in humans and laboratory animals, Arch Toxicol, 89, 1727, 10.1007/s00204-015-1525-6 Liu, 2013, Aberrant TGF-beta1 signaling contributes to the development of primary biliary cirrhosis in murine model, World J Gastroenterol, 19, 5828, 10.3748/wjg.v19.i35.5828 Peng, 2019, Activation of Nrf2 by costunolide provides neuroprotective effect in PC12 cells, Food Funct, 10, 4143, 10.1039/C8FO02249F Panyod, 2020, Beneficial effects of Chinese herbs in the treatment of fatty liver diseases, J. Tradit. Compl. Med., 10, 260 Xing, 2022, Cardiorenal protective effect of costunolide against doxorubicin-induced toxicity in rats by modulating oxidative stress, inflammation and apoptosis, Molecules, 27, 10.3390/molecules27072122 Jin, 2020, Costunolide inhibits osteosarcoma growth and metastasis via suppressing STAT3 signal pathway, Biomed Pharmacother = Biomed Pharmacother, 121 Matsuda, 2002, Inhibitory mechanism of costunolide, a sesquiterpene lactone isolated from Laurus nobilis, on blood-ethanol elevation in rats: involvement of inhibition of gastric emptying and increase in gastric juice secretion, Alcohol Alcohol, 37, 121, 10.1093/alcalc/37.2.121 Gong, 2016, Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis, Oncotarget, 7, 83951, 10.18632/oncotarget.13796 Allen, 2011, Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis, Am J Pathol, 178, 175, 10.1016/j.ajpath.2010.11.026 Zhu, 2016, Bile acids in regulation of inflammation and immunity: friend or foe?, Clin Exp Rheumatol, 34, 25